Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FormuMax Scientific is a biotechnology company specializing in advanced liposome and lipid nanoparticle (LNP) technologies for drug delivery. The company provides a comprehensive suite of catalog liposome products, including clodronate liposomes for macrophage depletion and specialized kits for mRNA and DNA encapsulation. In addition to its product offerings, FormuMax operates as a contract research and manufacturing organization, assisting pharmaceutical partners with formulation development, analytical testing, and process scale-up. Their platform supports the delivery of a wide range of therapeutic agents, including small molecules, peptides, and nucleic acids, with a primary focus on oncology, vaccines, and gene therapy applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FormuMax Scientific.